Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Kythera Biopharmaceuticals has appointed John Smither as chief financial officer and has given him responsibility for all financial and administrative aspects of the company.
Subscribe to our email newsletter
Mr Smither spent more than nine years at Amgen, where he advanced rapidly through financial management positions for business units and subsidiaries based in Europe and the US. During his term as chief financial officer of Amgen Europe, Smither directed financial planning, accounting, cost accounting, treasury, cash management and financial reporting under US GAAP in 25 European countries.
Keith Leonard, CEO of Kythera, said: “As Kythera moves to its next round of funding and prepares for access to public markets, we are fortunate to have someone of John’s caliber and financial prowess to lead the effort.”